Pathogenicity, penetrance, and de novo are scientific terms that come up often when reading about genetic mutations. What do they mean?
Guide to family planning in familial Alzheimer's disease
Estate planning for familial Alzheimer's disease
Estate planning attorney Kurt Walberg walks families through essential estate planning steps that can bring peace of mind when navigating life with familial Alzheimer's disease FAD. From medical powers of attorney to wills and trusts, this talk covers the tools you need to ensure your wishes are honored — even in the face of uncertainty.
Resources for non-familial early-onset Alzheimer's disease
Planning for care in familial Alzheimer's disease
In this session, Vanessa Souza from the Alzheimer’s Association discusses how to plan for care when facing Familial Alzheimer’s Disease (FAD). Whether you’re navigating a diagnosis, supporting a loved one, or just planning ahead, this video covers everything from legal documents and financial planning, employment choices, making meaningful memories, and adjustments to stay independent for longer.
How genetic mutations cause familial Alzheimer’s disease
Lifestyle interventions for brain health, with Dr. Rudy Tanzi
In familial Alzheimer’s disease, what is an “escapee”?
What is autosomal dominant inheritance?
What is a genome?
A genome is the complete set of genetic instructions fundamental to the development and function of an organism. It encompasses all the genes across the 23 pairs of chromosomes in humans, acting as a detailed instruction manual for making and maintaining an individual. Chromosomes serve as chapters in this manual, with genes as the step-by-step directions for various biological processes.
Genetic variants vs. genetic mutations
What are chromosomes?
Dementia vs Alzheimer's disease
Talking to kids about familial Alzheimer's disease: an interview with Dr. Hennig-Trestman
In an interview with Youngtimers founder Lindsay Hohsfield, professor and author Dr. Bonnie Hennig-Trestman offers expert advice on how to talk to children about familial Alzheimer's disease (FAD). Based upon her decades of experience with Huntington’s Disease (HD), Dr. Hennig-Trestman’s shares age-appropriate strategies, communication tips, and emotional support techniques to help families foster trust — even when the future feels uncertain.
Mental health techniques from Dr. Cynthia Wilcox
During the fall of 2023, Dr. Cynthia Wilcox joined us for a 3-part Workshop Series on the topic of Mental Health. The experiential workshops focused on skills for the FAD journey, including how to process overwhelming thoughts and emotions, strategies and skills for caring for our own physical and emotional wellbeing, and learning how to make room for beauty and joy in addition to sorrow.
Talking to kids about familial Alzheimer's disease: a live webinar with Dr. Hennig-Trestman
In this live interview, Youngtimers volunteer Susan Hiatt interviews professor and author Dr. Bonnie Hennig-Trestman about talking to children about familial Alzheimer's disease (FAD). Drawing on decades of experience studying families with Huntington’s Disease, Dr. Hennig-Trestman shares age-appropriate strategies, communication tips, and emotional support techniques to help families foster trust.
Caring for kids when a parent has familial Alzheimer’s disease: a chat with Dr. Gelman and Dr. Sikes
Explore the emotional and developmental impact of early-onset familial Alzheimer’s disease on children and young adults in this expert conversation with Dr. Caroline Gelman and Dr. Pat Sikes. Learn about caregiving challenges, emotional burdens, and practical support strategies for families navigating this rare condition.
Jetske's story: Overcoming isolation in the face of familial Alzheimer's genetics
In this interview, we speak with a member of the Youngtimers community who is a public advocate, a researcher and a strong voice for FAD. She has published a book and appeared on television in the Netherlands, sharing her own genetic story to help reduce isolation surrounding familial Alzheimer’s disease.
A deeper discussion of Alzheimer’s research participation with Dr. Randall Bateman
This interview is the second of a 2-part series with Dr. Randall Bateman about Alzheimer’s disease clinical trials participation. We discuss how data and samples from the DIAN and DIAN-TU studies accelerate progress worldwide, the importance of continued study participation, brain donation, new tau-targeting drug trials, and more.